IRDiRC is pleased to announce the election of Dr David Pearce, President of Innovation, Research & World Clinics, Sanford Health (USA), as the next Chair of the IRDiRC Consortium Assembly. Dr Pearce is replacing Dr Lucia Monaco, ex Lead of the Research Impact and Strategic Analysis team at Fondazione Telethon (Italy).
Ms Samantha Parker, Chief Patient Access Officer at InnoSkel (France), is elected Vice Chair of the IRDiRC Consortium Assembly and replaces Dr. Pearce in his former role.
From L to R: Ms Samantha Parker, Dr. David Pearce, Dr. Lucia Monaco with Dr. Daria Julkowska (IRDiRC Scientific Secretariat Coordinator)
The term of Dr Pearce and Ms Parker run from January 1st, 2022 until December 31st, 2024.